-
1
-
-
0024413449
-
Systemic effects of tissue plasminogen activator-associated fibrinolysis and its relation to thrombin generation in orthotopic liver transplantation
-
Porte RJ, Bontempo FA, Knot EA, Lewis JH, Kang YG, Starzl TE,. Systemic effects of tissue plasminogen activator-associated fibrinolysis and its relation to thrombin generation in orthotopic liver transplantation. Transplantation 1989; 47: 978-984.
-
(1989)
Transplantation
, vol.47
, pp. 978-984
-
-
Porte, R.J.1
Bontempo, F.A.2
Knot, E.A.3
Lewis, J.H.4
Kang, Y.G.5
Starzl, T.E.6
-
2
-
-
0025063231
-
Aprotinin and reduction of blood loss and transfusion requirements in orthotopic liver transplantation
-
Mallett SV, Cox D, Burroughs AK, Rolles K,. Aprotinin and reduction of blood loss and transfusion requirements in orthotopic liver transplantation. Lancet 1990; 336: 886-887.
-
(1990)
Lancet
, vol.336
, pp. 886-887
-
-
Mallett, S.V.1
Cox, D.2
Burroughs, A.K.3
Rolles, K.4
-
3
-
-
0034655629
-
Aprotinin and transfusion requirements in orthotopic liver transplantation: A multicentre randomised double-blind study
-
EMSALT Study Group.
-
Porte RJ, Molenaar IQ, Begliomini B, Groenland TH, Januszkiewicz A, Lindgren L, et al. Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study. EMSALT Study Group. Lancet 2000; 355: 1303-1309.
-
(2000)
Lancet
, vol.355
, pp. 1303-1309
-
-
Porte, R.J.1
Molenaar, I.Q.2
Begliomini, B.3
Groenland, T.H.4
Januszkiewicz, A.5
Lindgren, L.6
-
4
-
-
41149127789
-
Requirements for transfusion and postoperative outcomes in orthotopic liver transplantation: A meta-analysis on aprotinin
-
Liu CM, Chen J, Wang XH,. Requirements for transfusion and postoperative outcomes in orthotopic liver transplantation: a meta-analysis on aprotinin. World J Gastroenterol 2008; 14: 1425-1429.
-
(2008)
World J Gastroenterol
, vol.14
, pp. 1425-1429
-
-
Liu, C.M.1
Chen, J.2
Wang, X.H.3
-
5
-
-
31344467254
-
The risk associated with aprotinin in cardiac surgery
-
for Multicenter Study of Perioperative Ischemia Research Group and Ischemia Research and Education Foundation.
-
Mangano DT, Tudor IC, Dietzel C,; for Multicenter Study of Perioperative Ischemia Research Group and Ischemia Research and Education Foundation. The risk associated with aprotinin in cardiac surgery. N Engl J Med 2006; 354: 353-365.
-
(2006)
N Engl J Med
, vol.354
, pp. 353-365
-
-
Mangano, D.T.1
Tudor, I.C.2
Dietzel, C.3
-
6
-
-
44349089188
-
A comparison of aprotinin and lysine analogues in high-risk cardiac surgery
-
et al.; for BART Investigators.
-
Fergusson DA, Hébert PC, Mazer CD, Fremes S, MacAdams C, Murkin JM, et al.; for BART Investigators. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 2008; 358: 2319-2331.
-
(2008)
N Engl J Med
, vol.358
, pp. 2319-2331
-
-
Fergusson, D.A.1
Hébert, P.C.2
Mazer, C.D.3
Fremes, S.4
MacAdams, C.5
Murkin, J.M.6
-
7
-
-
79959474965
-
Detrimental effect of aprotinin ban on amount of blood loss during liver transplantation: Single-center experience
-
Trzebicki J, Kosieradzki M, Flakiewicz E, Kuzminska G, Wasiak D, Pacholczyk M, et al. Detrimental effect of aprotinin ban on amount of blood loss during liver transplantation: single-center experience. Transplant Proc 2011; 43: 1725-1727.
-
(2011)
Transplant Proc
, vol.43
, pp. 1725-1727
-
-
Trzebicki, J.1
Kosieradzki, M.2
Flakiewicz, E.3
Kuzminska, G.4
Wasiak, D.5
Pacholczyk, M.6
-
8
-
-
33645321129
-
Comparison of the effects of aprotinin and tranexamic acid on blood loss and red blood cell transfusion requirements during the late stages of liver transplantation
-
Ickx BE, van der Linden PJ, Melot C, Wijns W, de Pauw L, Vandestadt J, et al. Comparison of the effects of aprotinin and tranexamic acid on blood loss and red blood cell transfusion requirements during the late stages of liver transplantation. Transfusion 2006; 46: 595-605.
-
(2006)
Transfusion
, vol.46
, pp. 595-605
-
-
Ickx, B.E.1
Van Der Linden, P.J.2
Melot, C.3
Wijns, W.4
De Pauw, L.5
Vandestadt, J.6
-
9
-
-
79958250005
-
Aprotinin versus tranexamic acid during liver transplantation: Impact on blood product requirements and survival
-
Massicotte L, Denault AY, Beaulieu D, Thibeault L, Hevesi Z, Roy A,. Aprotinin versus tranexamic acid during liver transplantation: impact on blood product requirements and survival. Transplantation 2011; 91: 1273-1278.
-
(2011)
Transplantation
, vol.91
, pp. 1273-1278
-
-
Massicotte, L.1
Denault, A.Y.2
Beaulieu, D.3
Thibeault, L.4
Hevesi, Z.5
Roy, A.6
-
10
-
-
33845651348
-
Efficacy and safety of antifibrinolytic drugs in liver transplantation: A systematic review and meta-analysis
-
Molenaar IQ, Warnaar N, Groen H, Tenvergert EM, Slooff MJ, Porte RJ,. Efficacy and safety of antifibrinolytic drugs in liver transplantation: a systematic review and meta-analysis. Am J Transplant 2007; 7: 185-194.
-
(2007)
Am J Transplant
, vol.7
, pp. 185-194
-
-
Molenaar, I.Q.1
Warnaar, N.2
Groen, H.3
Tenvergert, E.M.4
Slooff, M.J.5
Porte, R.J.6
-
11
-
-
0028272043
-
A fatal thrombotic complication during liver transplantation after aprotinin administration
-
Baubillier E, Cherqui D, Dominique C, Khalil M, Bonnet F, Fagniez PL, Duvaldestin P,. A fatal thrombotic complication during liver transplantation after aprotinin administration. Transplantation 1994; 57: 1664-1666.
-
(1994)
Transplantation
, vol.57
, pp. 1664-1666
-
-
Baubillier, E.1
Cherqui, D.2
Dominique, C.3
Khalil, M.4
Bonnet, F.5
Fagniez, P.L.6
Duvaldestin, P.7
-
12
-
-
1242329511
-
Intravascular thrombosis and thromboembolism during liver transplantation: Antifibrinolytic therapy implicated?
-
Ramsay MA, Randall HB, Burton EC,. Intravascular thrombosis and thromboembolism during liver transplantation: antifibrinolytic therapy implicated? Liver Transpl 2004; 10: 310-314.
-
(2004)
Liver Transpl
, vol.10
, pp. 310-314
-
-
Ramsay, M.A.1
Randall, H.B.2
Burton, E.C.3
-
13
-
-
34548303791
-
The impact of aprotinin on renal function after liver transplantation: An analysis of 1,043 patients
-
Warnaar N, Mallett SV, de Boer MT, Rolando N, Burroughs AK, Nijsten MW, et al. The impact of aprotinin on renal function after liver transplantation: an analysis of 1,043 patients. Am J Transplant 2007; 7: 2378-2387.
-
(2007)
Am J Transplant
, vol.7
, pp. 2378-2387
-
-
Warnaar, N.1
Mallett, S.V.2
De Boer, M.T.3
Rolando, N.4
Burroughs, A.K.5
Nijsten, M.W.6
-
14
-
-
0023204701
-
Effect of aprotinin on need for blood transfusion after repeat open-heart surgery
-
Royston D, Bidstrup BP, Taylor KM, Sapsford RN,. Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet 1987; 2: 1289-1291.
-
(1987)
Lancet
, vol.2
, pp. 1289-1291
-
-
Royston, D.1
Bidstrup, B.P.2
Taylor, K.M.3
Sapsford, R.N.4
-
16
-
-
0028077632
-
Role of the donor liver in the origin of platelet disorders and hyperfibrinolysis in liver transplantation
-
Porte RJ, Blauw E, Knot EA, de Maat MP, de Ruiter C, Minke Bakker C, Terpstra OT,. Role of the donor liver in the origin of platelet disorders and hyperfibrinolysis in liver transplantation. J Hepatol 1994; 21: 592-600.
-
(1994)
J Hepatol
, vol.21
, pp. 592-600
-
-
Porte, R.J.1
Blauw, E.2
Knot, E.A.3
De Maat, M.P.4
De Ruiter, C.5
Minke Bakker, C.6
Terpstra, O.T.7
-
17
-
-
68349131341
-
Aprotinin and the risk of thrombotic complications after liver transplantation: A retrospective analysis of 1492 patients
-
Warnaar N, Mallett SV, Klinck JR, de Boer MT, Rolando N, Burroughs AK, et al. Aprotinin and the risk of thrombotic complications after liver transplantation: a retrospective analysis of 1492 patients. Liver Transpl 2009; 15: 747-753.
-
(2009)
Liver Transpl
, vol.15
, pp. 747-753
-
-
Warnaar, N.1
Mallett, S.V.2
Klinck, J.R.3
De Boer, M.T.4
Rolando, N.5
Burroughs, A.K.6
-
18
-
-
0033917175
-
Tranexamic acid reduces red cell transfusion better than epsilon-aminocaproic acid or placebo in liver transplantation
-
Dalmau A, Sabaté A, Acosta F, Garcia-Huete L, Koo M, Sansano T, et al. Tranexamic acid reduces red cell transfusion better than epsilon-aminocaproic acid or placebo in liver transplantation. Anesth Analg 2000; 91: 29-34.
-
(2000)
Anesth Analg
, vol.91
, pp. 29-34
-
-
Dalmau, A.1
Sabaté, A.2
Acosta, F.3
Garcia-Huete, L.4
Koo, M.5
Sansano, T.6
-
19
-
-
33749055499
-
Coagulation management during liver transplantation [in German]
-
Görlinger K,. Coagulation management during liver transplantation [in German]. Hamostaseologie 2006; 26 (suppl 1): S64-S76.
-
(2006)
Hamostaseologie
, vol.26
, Issue.SUPPL. 1
-
-
Görlinger, K.1
-
20
-
-
84863956158
-
Resource implications of expanding the use of donation after circulatory determination of death in liver transplantation
-
Broomhead RH, Patel S, Fernando B, O'Beirne J, Mallett S,. Resource implications of expanding the use of donation after circulatory determination of death in liver transplantation. Liver Transpl 2012; 18: 771-778.
-
(2012)
Liver Transpl
, vol.18
, pp. 771-778
-
-
Broomhead, R.H.1
Patel, S.2
Fernando, B.3
O'Beirne, J.4
Mallett, S.5
-
21
-
-
84856344486
-
Methods to decrease blood loss and transfusion requirements for liver transplantation
-
CD009052
-
Gurusamy KS, Pissanou T, Pikhart H, Vaughan J, Burroughs AK, Davidson BR,. Methods to decrease blood loss and transfusion requirements for liver transplantation. Cochrane Database Syst Rev 2011: CD009052.
-
(2011)
Cochrane Database Syst Rev
-
-
Gurusamy, K.S.1
Pissanou, T.2
Pikhart, H.3
Vaughan, J.4
Burroughs, A.K.5
Davidson, B.R.6
-
22
-
-
0034767540
-
Aprotinin in orthotopic liver transplantation: Evidence for a prohemostatic, but not a prothrombotic, effect
-
Molenaar IQ, Legnani C, Groenland TH, Palareti G, Begliomini B, Terpstra OT, Porte RJ,. Aprotinin in orthotopic liver transplantation: evidence for a prohemostatic, but not a prothrombotic, effect. Liver Transpl 2001; 7: 896-903.
-
(2001)
Liver Transpl
, vol.7
, pp. 896-903
-
-
Molenaar, I.Q.1
Legnani, C.2
Groenland, T.H.3
Palareti, G.4
Begliomini, B.5
Terpstra, O.T.6
Porte, R.J.7
|